Source: FDA, National Drug Code (US) Revision Year: 2020
LAMPIT contains nifurtimox, an antiprotozoal. The chemical name is (E)N(3-Methyl-1,1-dioxidothiomorpholin-4-yl)1(5-nitro-2-furyl)methanimine.
The molecular weight is 287.29 and the molecular formula is C10H13N3O5S.
The structural formula is:
LAMPIT (nifurtimox) tablets are yellow round, biconvex tablets, each containing 30 mg or 120 mg of nifurtimox, intended for oral use. The 30 mg tablets are functionally scored on one side and marked with ‘30’ on the other side. The 120 mg tablets are functionally scored on one side and marked with ‘120’ on the other side.
The inactive ingredients of the tablets are as follows: calcium hydrogen phosphate dihydrate, magnesium stearate, maize starch, silica colloidal anhydrous and sodium lauryl sulfate.
| Dosage Forms and Strengths |
|---|
|
LAMPIT tablets are available as 30 mg and 120 mg tablets.
|
| How Supplied |
|---|
|
LAMPIT tablets are supplied as follows:
LAMPIT tablets 30 mg are supplied as bottles of 100 tablets with child-resistant closures (NDC 50419-750-01). LAMPIT tablets 120 mg are supplied as bottles of 100 tablets with child-resistant closures (NDC 50419-751-01). |
| Drug | Countries | |
|---|---|---|
| LAMPIT | United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
